2017
DOI: 10.1016/j.biopha.2016.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
11
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 18 publications
0
11
0
1
Order By: Relevance
“…The upregulation of CEBPB-CLDN4 signaling caused the migration and invasion of cancer cell [41]. Homeobox A5 (HOXA5) is a member of the homeobox (HOX) family and is upregulated in many types of tumors [42]. Forkhead box L1 (FOXL1) is a member of the Forkhead box (FOX) superfamily and was reported to be dysregulated in various types of cancers.…”
Section: Discussionmentioning
confidence: 99%
“…The upregulation of CEBPB-CLDN4 signaling caused the migration and invasion of cancer cell [41]. Homeobox A5 (HOXA5) is a member of the homeobox (HOX) family and is upregulated in many types of tumors [42]. Forkhead box L1 (FOXL1) is a member of the Forkhead box (FOX) superfamily and was reported to be dysregulated in various types of cancers.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have demonstrated that HOXA5 plays a significant role in tumor development. The heterotopic expression of HOXA5 was found to promote the proliferation and differentiation of esophageal cancer (31). Zhang et al demonstrated that HOXA5 could constrain cell proliferation via modulating p21 in non-small cell lung cancer (32).…”
Section: Discussionmentioning
confidence: 99%
“…Strikingly, very few candidate target genes are components or essential regulators of the Wnt/β-catenin, FGF, and TGF-β/Activin/BMP signaling pathways that have been identified as downstream pathways of several HOX proteins in embryonic development, neural differentiation and tumorigenesis ( Chen et al, 2005 ; Schiedlmeier et al, 2007 ; Bami et al, 2011 ; Makki and Capecchi, 2011 ; Donaldson et al, 2012 ; Carroll and Capecchi, 2015 ; Duan et al, 2015 ; Hrycaj et al, 2015 ; Roux et al, 2015 ; Karmakar et al, 2017 ; Zhang et al, 2017 ). Moreover, except from Pcp2 (see Supplementary Table S3 , line 17), none of the already identified direct or indirect targets of HOXA5 was significantly downregulated in our analysis (e.g., Ptn, Fslt1 ) ( Sanlioglu et al, 1998 ; Chen et al, 2005 ; Boucherat et al, 2013 ).…”
Section: Discussionmentioning
confidence: 99%